结果二十一名病人符合纳入标准。
两名评论者评估论文纳入标准和品质。
Two reviewer authors evaluated the papers for inclusion criteria and quality.
纳入标准：涉及艺术疗法与绘画疗法。
Inclusive criteria: articles about art therapy and drawing therapy.
纳入标准为随机、对照实验。
Inclusion criteria were for those randomized controlled experiments.
符合纳入标准的文章32篇，排除71篇。
纳入标准：无心脏疾患，体格发育匀称的儿童。
Including criteria: children had no heart diseases and with symmetry physique development.
纳入标准：相关研究、归因研究、干预性研究。
Inclusive criteria: related research, attribution research and intervention research.
我们没有确认任何符合这篇回顾纳入标准的研究。
We did not identify any studies that met the inclusion criteria for this review.
我们没有发现任何研究符合这篇回顾的纳入标准。
We did not find any studies that met the inclusion criteria for this review.
纳入标准：光纤dna传感器在基因检测中的应用。
Inclusive criteria: The application of optical fiber DNA biosensor in gene detecting.
二位作者应用纳入标准，估计试验品质，并且提取数据。
The two authors applied the inclusion criteria, assessed trial quality, and extracted the data.
纳入标准：文章所述内容应与体育及心理健康研究相关。
Inclusive criteria: the contents related with sports and psychological health.
应研发纳入标准的降低闯入危险性的技术，并最终纳入规定。
Intrusion mitigation techniques should be developed for incorporation into standards and eventually, into regulations.
在116项可能相关的研究中，42项临床试验符合此纳入标准。
Of 116 potentially relevant studies, 42 trials met the inclusion criteria.
纳入标准为C3到C7单阶段脊髓病和脊柱滑脱或椎间盘突出患者。
The inclusion criteria were myelopathy and spondylosis or disc herniation at a single level from C3 to C7.
每项研究对受试者的纳入标准不尽相同，但它们全部包含对哮喘的诊断。
The inclusion criteria for the participants in each study varied but all had a diagnosis of asthma.
方法：回顾性分析符合纳入标准的214例服用华法林患者的相关临床资料。
METHODS: a retrospective analysis of related clinical data of 214 patients who meet the inclusion criteria was performed.
资料提炼：共收集到58篇相关论文，其中13篇符合纳入标准，排除45篇。
DATA EXTRACTION: Totally 58 related articles were collected, among which 13 met the inclusion criteria and 45 were excluded.
资料提炼：共检索到关于皮肤瘢痕的文献178篇，13篇文献符合纳入标准。
DATA EXTRACTION: 178 articles about skin scar were collected, in which 13 articles were in accordance with the criteria.
资料提炼：共收集到589篇与人工膝关节置换术相关的文献，其中20篇符合纳入标准。
DATA EXTRACTION: Totally 589 relevant literatures were collected, and 20 of them were in accordance with the inclusive criteria.
资料提炼：共收集到35篇关于脑卒中后常见并发症的相关文献，18个试验符合纳入标准。
DATA EXTRACTION: a total of 35 articles related to the common complications of stroke were collected, 18 of which were in accordance with the inclusive criteria.
资料提炼：共收集到74篇有关白细胞介素及其受体的文章，31个实验或临床研究纳入标准。
DATA EXTRACTION: a total of 74 articles about interleukin receptors were collected, and 31 experimental or clinical studies were in accordance with the inclusion criteria.
此外，我们确认了其他18个只在临床试验注册但并没有相关结果或发表符合纳入标准的试验。
Furthermore, we identified an additional 18 potentially eligible trials that were reported only in clinical trial registers with no associated results or publications.
纳入标准：有关成肌细胞的生物学特性、在骨骼肌收缩中的应用、在基因治疗中应用方面的文献。
Inclusive criteria: Literature about the biological characteristics of myoblast, the application in skeletal muscle contraction and gene treatment.
资料提炼：共收集到符合上述要求的文献62篇，排除28篇重复性研究。34篇符合纳入标准。
DATA EXTRACTION: There were 62 literatures in accordance with the criteria, 28 repeated ones were excluded, and 34 articles met the inclusion criteria.
资料提炼：共收集到符合上述要求的文献40篇，排除27篇重复性研究，13篇符合纳入标准。
DATA EXTRACTION: There were 40 literatures in accordance with the above criteria, 27 repetitive studies were excluded, and 13 were accorded with the inclusive criteria.
纳入标准：从神经心理学或医学、临床心理学的角度，对大脑功能与活动进行研究和实验的文章。
Inclusive criteria: those papers that discussed about the function of brain and psychological activities from the angles of neuropsychology, or medical and clinical psychology.
纳入标准：经典文献、经严格科学设计的基础实验研究、前瞻性随机性临床研究及病例对照研究。
Inclusion criteria: Typical literatures, basic experimental research that restrictedly and scientifically designed, prospective randomized clinical research as well as case control study.
结果：共有47例完成了试验，其中喷昔洛韦组23例，1例不符合纳入标准。阿昔洛韦组24例。
RESULTS: Totally 47 patients finished the trial, 23 in the trial group, among which 1 was not accordant with the inclusion criteria, and 24 in the control group.
结果：共有47例完成了试验，其中喷昔洛韦组23例，1例不符合纳入标准。阿昔洛韦组24例。
RESULTS: Totally 47 patients finished the trial, 23 in the trial group, among which 1 was not accordant with the inclusion criteria, and 24 in the control group.
应用推荐